about
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing...
Read More
24.27
0.45
(1.89%)
31,136
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for SpyGlass Pharma Inc took place on 14 May 2026, for the purpose of SpyGlass Pharma Inc Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
SpyGlass Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..